International Clinical Trial: A single-center, open-label IIT study evaluated the efficacy and safety of tumor electric field therapy combined with gemcitabine and albumin-bound paclitaxel in the treatment of advanced pancreatic cancer

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131799) titled 'A single-center, open-label IIT study evaluated the efficacy and safety of tumor electric field therapy combined with gemcitabine and albumin-bound paclitaxel in the treatment of advanced pancreatic cancer' on Sept. 7.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Fudan University Affiliated Cancer Hospital

Condition: Pancreatic cancer

Intervention: Queue A :Subjects in queue A received electric field therapy (150kHz, with a recommended daily usage time of =18 hours/day) daily during the trial period. Queue B:Queue B and C were on the 4th to 6th days of each week (the 1st, 8th,...